Literature DB >> 6308558

ATA box transcription mutation in beta-thalassemia.

S H Orkin, J P Sexton, T C Cheng, S C Goff, P J Giardina, J I Lee, H H Kazazian.   

Abstract

DNA sequence analysis of a cloned beta-globin gene from a Chinese patient with beta-thalassemia revealed a single nucleotide substitution (A leads to G) within the ATA box homology and 28 base pairs upstream from the cap site. The patient was homozygous for this particular allele based on restriction mapping at nine different polymorphic sites in the beta-globin gene cluster. Upon transient expression in HeLa cells this gene directed the production of 3-5-fold less beta-globin mRNA than the normal beta-gene. In RNA isolated from the patient's erythroid cells beta-RNA was 10-fold less abundant relative to alpha-RNA than normal, indicating close approximation of the heterologous cell expression results and the in vivo state. These findings support the validity of such transient expression assays for analysis of phenotypes associated with naturally occurring mutant genes and establish the functional significance of nucleotide substitutions at position -28 for human beta-globin gene transcription.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6308558      PMCID: PMC326082          DOI: 10.1093/nar/11.14.4727

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  23 in total

1.  Mapping of RNA by a modification of the Berk-Sharp procedure: the 5' termini of 15 S beta-globin mRNA precursor and mature 10 s beta-globin mRNA have identical map coordinates.

Authors:  R F Weaver; C Weissmann
Journal:  Nucleic Acids Res       Date:  1979-11-10       Impact factor: 16.971

2.  Transcription maps of polyoma virus-specific RNA: analysis by two-dimensional nuclease S1 gel mapping.

Authors:  J Favaloro; R Treisman; R Kamen
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

3.  Nonrandom association of polymorphic restriction sites in the beta-globin gene cluster.

Authors:  S E Antonarakis; C D Boehm; P J Giardina; H H Kazazian
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

4.  Expression of a beta-globin gene is enhanced by remote SV40 DNA sequences.

Authors:  J Banerji; S Rusconi; W Schaffner
Journal:  Cell       Date:  1981-12       Impact factor: 41.582

5.  A T to A base substitution and small deletions in the conalbumin TATA box drastically decrease specific in vitro transcription.

Authors:  B Wasylyk; P Chambon
Journal:  Nucleic Acids Res       Date:  1981-04-24       Impact factor: 16.971

6.  Beta + thalassemia: aberrant splicing results from a single point mutation in an intron.

Authors:  M Busslinger; N Moschonas; R A Flavell
Journal:  Cell       Date:  1981-12       Impact factor: 41.582

Review 7.  Organization and expression of eucaryotic split genes coding for proteins.

Authors:  R Breathnach; P Chambon
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

8.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

9.  The structure and evolution of the human beta-globin gene family.

Authors:  A Efstratiadis; J W Posakony; T Maniatis; R M Lawn; C O'Connell; R A Spritz; J K DeRiel; B G Forget; S M Weissman; J L Slightom; A E Blechl; O Smithies; F E Baralle; C C Shoulders; N J Proudfoot
Journal:  Cell       Date:  1980-10       Impact factor: 41.582

10.  Specific in vitro transcription of conalbumin gene is drastically decreased by single-point mutation in T-A-T-A box homology sequence.

Authors:  B Wasylyk; R Derbyshire; A Guy; D Molko; A Roget; R Téoule; P Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  32 in total

1.  The molecular basis of thalassemias.

Authors:  S Fucharoen; P Winichagoon
Journal:  Indian J Pediatr       Date:  1989 Nov-Dec       Impact factor: 1.967

2.  Homozygous hypobetalipoproteinemia: a disease distinct from abetalipoproproteinemia at the molecular level.

Authors:  R S Ross; R E Gregg; S W Law; J C Monge; S M Grant; K Higuchi; T J Triche; J Jefferson; H B Brewer
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

3.  A novel -32 (C-A) mutant identified in amplified genomic DNA of a Chinese beta-thalassemic patient.

Authors:  L I Lin; K S Lin; K H Lin; T Y Cheng
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

4.  Cis and trans activation of adenovirus IVa2 gene transcription.

Authors:  V Natarajan; N P Salzman
Journal:  Nucleic Acids Res       Date:  1985-06-11       Impact factor: 16.971

5.  The same "TATA" box beta-thalassemia mutation in Chinese and US blacks: another example of independent origins of mutation.

Authors:  S Huang; C Wong; S E Antonarakis; T Ro-lien; W H Lo; H H Kazazian
Journal:  Hum Genet       Date:  1986-10       Impact factor: 4.132

6.  Acetylation pharmacogenetics. The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver.

Authors:  D M Grant; K Mörike; M Eichelbaum; U A Meyer
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

7.  A fetal globin gene mutation in A gamma nondeletion hereditary persistence of fetal hemoglobin increases promoter strength in a nonerythroid cell.

Authors:  M W Rixon; R E Gelinas
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

8.  A new TATA box mutation detected at prenatal diagnosis for beta-thalassemia.

Authors:  S P Cai; J Z Zhang; M Doherty; Y W Kan
Journal:  Am J Hum Genet       Date:  1989-07       Impact factor: 11.025

9.  Linker scanning mutagenesis of the 5'-flanking region of the mouse beta-major-globin gene: sequence requirements for transcription in erythroid and nonerythroid cells.

Authors:  P Charnay; P Mellon; T Maniatis
Journal:  Mol Cell Biol       Date:  1985-06       Impact factor: 4.272

10.  An experimental verification of the predicted effects of promoter TATA-box polymorphisms associated with human diseases on interactions between the TATA boxes and TATA-binding protein.

Authors:  Ludmila Savinkova; Irina Drachkova; Tatyana Arshinova; Petr Ponomarenko; Mikhail Ponomarenko; Nikolay Kolchanov
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.